DCLK1 and esophageal adenocarcinoma: Other studies indicate that DCLK1 has been shown to be expressed in the stroma of colon, pancreatic, prostate, breast cancers, esophageal adenocarcinoma, and non-small cell lung cancer (NSCLC) (Sureban et al. 2011; Whorton et al. 2015; Tao et al. 2017).